Skip to main content
Article thumbnail
Location of Repository

Ablation of NG2 Proteoglycan Leads to Deficits in Brown Fat Function and to Adult Onset Obesity

By Yunchao Chang, Zhi-Gang She, Kenji Sakimura, Amanda Roberts, Karolina Kucharova, David H. Rowitch and William B. Stallcup

Abstract

Obesity is a major health problem worldwide. We are studying the causes and effects of obesity in C57Bl/6 mice following genetic ablation of NG2, a chondroitin sulfate proteoglycan widely expressed in progenitor cells and also in adipocytes. Although global NG2 ablation delays early postnatal adipogenesis in mouse skin, adult NG2 null mice are paradoxically heavier than wild-type mice, exhibiting larger white fat deposits. This adult onset obesity is not due to NG2-dependent effects on CNS function, since specific ablation of NG2 in oligodendrocyte progenitors yields the opposite phenotype; i.e. abnormally lean mice. Metabolic analysis reveals that, while activity and food intake are unchanged in global NG2 null mice, O2 consumption and CO2 production are decreased, suggesting a decrease in energy expenditure. Since brown fat plays important roles in regulating energy expenditure, we have investigated brown fat function via cold challenge and high fat diet feeding, both of which induce the adaptive thermogenesis that normally occurs in brown fat. In both tests, body temperatures in NG2 null mice are reduced compared to wild-type mice, indicating a deficit in brown fat function in the absence of NG2. In addition, adipogenesis in NG2 null brown pre-adipocytes is dramatically impaired compared to wild-type counterparts. Moreover, mRNA levels for PR domain containing 16 (PRDM16) and peroxisome proliferator-activated receptor γ coactivator (PGC)1-α, proteins important for brown adipocyte differentiation, are decreased in NG2 null brown fat deposits in vivo and NG2 null brown pre-adipocytes in vitro. Altogether, these results indicate that brown fat dysfunction in NG2 null mice results from deficits in the recruitment and/or development of brown pre-adipocytes. As a consequence, obesity in NG2 null mice may occur due to disruptions in brown fat-dependent energy homeostasis, with resulting effects on lipid storage in white adipocytes

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3266271
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1998). A coldinducible coactivator of nuclear receptors linked to adaptive thermogenesis.
    2. (2011). A new era for brown adipose tissue: New insights into brown adipocyte function and differentiation.
    3. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs.
    4. (2008). A role for the NG2 proteoglycan in glioma progression.
    5. (2008). Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.
    6. (2004). Brown adipose tissue: function and physiological significance.
    7. (1996). Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain.
    8. (2009). Cold-activated brown adipose tissue in healthy men.
    9. (2006). Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance.
    10. (2001). Cyclic AMP modulates the response of central nervous system glia to fibroblast growth factor-2 by redirecting signalling pathways.
    11. (2011). Different metabolic responses of human brown adipose tissue to activation by cold and insulin.
    12. (2007). Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration.
    13. (2003). Expression of NG2 proteoglycan during endochondral and intramembranous ossification.
    14. (2010). FGF but not EGF induces phosphorylation of the cAMP response element binding protein in olfactory mucosa-derived cell cultures.
    15. (2006). Fibroblast growth factor 2 applied to the optic nerve after axotomy up-regulates BDNF and TrkB in ganglion cells by activating the ERK and PKA signaling pathways.
    16. (2009). Functional brown adipose tissue in healthy adults.
    17. (1999). High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan.
    18. (2009). Identification and importance of brown adipose tissue in adult humans.
    19. (1996). Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats.
    20. (1984). Immortalization of primary mouse embryo fibroblasts with SV40 virions, viral DNA, and a subgenomic DNA fragment in a quantitative assay.
    21. (2006). Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.
    22. (2005). Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA.
    23. (2000). Involvement of protein kinase A in fibroblast growth factor-2-activated transcription.
    24. (2008). Liver X receptor alpha is a transcriptional repressor of the uncoupling protein 1 gene and the brown fat phenotype.
    25. (2009). Mechanical control of cAMP signaling through integrins is mediated by the heterotrimeric Galphas protein.
    26. (2009). MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity.
    27. (2008). New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure.
    28. (2002). NG2 proteoglycan expression by pericytes in pathological microvasculature.
    29. (2008). NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse.
    30. (2001). NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.
    31. (2004). NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin.
    32. (2007). Obesity and diabetes in the developing world–a growing challenge.
    33. (2003). Obesity is associated with macrophage accumulation in adipose tissue.
    34. (2004). Obesity wars: molecular progress confronts an expanding epidemic.
    35. (1995). Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor.
    36. (2004). Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
    37. (1999). PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse.
    38. (2010). Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.
    39. (2006). PGC-1alpha: a key regulator of energy metabolism.
    40. (2004). Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility.
    41. (2008). PRDM16 controls a brown fat/skeletal muscle switch.
    42. (2000). Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR.
    43. (2010). Sympathetic and sensory innervation of brown adipose tissue.
    44. (1991). The expression of NG2 proteoglycan in the developing rat limb.
    45. (2010). The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination.
    46. (2002). The NG2 proteoglycan: past insights and future prospects.
    47. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.
    48. (2000). Towards a molecular understanding of adaptive thermogenesis.
    49. (2007). Transcriptional control of brown fat determination by PRDM16.
    50. (2010). Transcriptional control of brown fat development.
    51. (2007). Unexpected evidence for active brown adipose tissue in adult humans.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.